# Shilpa Medicare’s Jadcherla unit gets GMP certification from AGES Austria 2026-10-11T02:07:52+00:00 | Governance | Indian Opinion Desk Corroboration: 2 independent outlets Shilpa Medicare’s Unit 4 in Jadcherla, Telangana, has received Good Manufacturing Practice (GMP) certification from AGES, Austria, following an inspection from July 27 to July 30, 2026. The company announced the certification in a regulatory filing on October 10. Unit 4 manufactures, tests, and distributes sterile injections and non-sterile tablets and capsules for markets in Europe and other global markets. Shilpa Medicare is headquartered in Raichur, Karnataka. In a separate development, Shilpa Medicare received final approval from the Subject Expert Committee (SEC) under CDSCO to market OERIS, an extended-release ondansetron injection for chemotherapy-induced nausea and vomiting. The product provides protection for up to five days after a single dose and is patent-protected in India until 2039. The company plans to launch OERIS commercially in India after receiving final marketing authorisation. ## Indian Opinion Analysis Both outlets report the GMP certification identically, leading with the regulatory filing and the July inspection dates. cnbctv18 adds the OERIS approval as a separate development, while medicaldialogues sticks solely to the certification news. The coverage is uniform straight reporting with no discernible slant from either source. Neither outlet offers commentary on the commercial significance or regulatory hurdles. The next concrete step is Shilpa Medicare’s planned commercial launch of OERIS after receiving final marketing authorisation. ## Coverage Coverage: 2 sources, 2 neutral - cnbctv18.com (neutral report) Straight regulatory filing report with added OERIS approval - medicaldialogues.in (neutral report) Pure GMP certification story, no additional developments This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Tags: AGES Austria, CDSCO, Shilpa Medicare Canonical: https://indianopinion.org/shilpa-medicares-jadcherla-unit-gets-gmp-certification-from-ages-austria/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/shilpa-medicares-jadcherla-unit-gets-gmp-certification-from-ages-austria/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/